ABSTRACT
Objetivo: descrever perfil e desfechos clínicos de pacientes diagnosticados com COVID-19 admitidos em hospital privado na região Sul do Brasil. Método: estudo descritivo, realizado com 110 pacientes com COVID-19 que necessitaram de internação hospitalar entre março e maio de 2020. Foram coletados dados sociodemográficos, perfil clínico, sinais e sintomas e desfechos clínicos. Adotou-se análise descritiva para interpretação dos dados. Resultados: predominou sexo masculino (64,5%). Comorbidade prevalente: Hipertensão Arterial Sistêmica (45,5%). Sinais e sintomas com maior destaque: tosse (53,6%) e dispneia (48,2%). Desfechos clínicos evidenciados: tomografia de tórax com opacidades em vidro fosco (98,2%), suplementação com oxigenoterapia (86,4%), encaminhamento para Unidade de Internação (90,9%). Intercorrências observadas: arritmias cardíacas (18,2%) e hipoxemia (18,2%). Desfecho final predominante foi alta melhorada (90%). Conclusão: a descrição de perfil e desfecho clínico de pacientes com COVID-19 proporcionará o direcionamento de cuidados com fluxos e protocolos assistenciais que garantam qualidade da assistência e segurança na prática clínica.
Objetivo: describir perfil y resultados clínicos de pacientes diagnosticados con COVID-19 admitidos en hospital privado en la región Sur de Brasil. Método: estudio descriptivo, realizado con 110 pacientes con COVID-19 que necesitaron de internación hospitalaria entre marzo y mayo de 2020. Se recogieron datos sociodemográficos, perfil clínico, signos y síntomas y resultados clínicos. Se adoptó análisis descriptivo para interpretación de los datos. Resultados: predominó sexo masculino (64,5%). Comorbilidad prevalente: Hipertensión Arterial Sistémica (45,5%). Signos y síntomas con mayor destaque: tos (53,6%) y disnea (48,2%). Resultados clínicos evidenciados: tomografía de tórax con opacidades en vidrio esmerilado (98,2%), suplementación con oxigenoterapia (86,4%), encaminamiento para Unidad de Internación (90,9%). Complicaciones observadas: arritmias cardíacas (18,2%) e hipoxemia (18,2%). Resultado final predominante fue alta mejorada (90%). Conclusión: la descripción de perfil y resultado clínico de pacientes con COVID-19 proporcionará la orientación de cuidados con flujos y protocolos asistenciales que garanticen calidad de la asistencia y seguridad en la práctica clínica.
Objective: to describe the clinical profile and outcomes of patients diagnosed with COVID-19 admitted to a private hospital in southern Brazil. Method: descriptive study, conducted with 110 patients with COVID-19 who required hospitalization between March and May 2020. Sociodemographic data, clinical profile, signs and symptoms, and clinical outcomes were collected. Descriptive analysis was adopted for data interpretation. Results: male predominated (64.5%). Prevalent comorbidity: Systemic Arterial Hypertension (45.5%). Signs and symptoms with greater prominence: cough (53.6%) and dyspnea (48.2%). Clinical outcomes evidenced: chest tomography with ground-glass opacities (98.2%), supplementation with oxygen therapy (86.4%), referral to the Hospitalization Unit (90.9%). Observed complications: cardiac arrhythmias (18.2%) and hypoxemia (18.2%). Predominant outcome was improved discharge (90%). Conclusion: the description of the clinical profile and outcome of patients with COVID-19 will provide the direction of care with care flows and protocols that guarantee quality of care and safety in clinical practice.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Health Profile , COVID-19/rehabilitation , Hospitalization , Treatment OutcomeABSTRACT
BACKGROUND: Patients affected by COVID-19 may develop an impaired lung function, with reduced lung capacities and volumes, respiratory muscle weakness, changes in radiographic and tomographic findings, limitations in exercising, decreased functional capacity, depression, anxiety and reduced quality of life. Thus, we aimed to analyze the effects of a pulmonary and functional rehabilitation program on the functional capacity, lung function and respiratory muscle strength in patients who were affected by COVID-19 syndrome. METHODS: This is a pilot clinical trial, composed of post-COVID-19 patients with mild, moderate or severe involvement, in which, they underwent a pulmonary and functional rehabilitation program. Patients were evaluated for functional capacity by the 6 min walk test, pulmonary function by spirometry, respiratory muscle strength by manovacuometry, handgrip strength by dynamometry, quality of life by the COPD Assessment Test and functional status by the PCFS. After the initial assessments, the patients performed the rehabilitation protocol in 16 sessions (inspiratory muscle training, aerobic exercise and peripheral muscle strength) and, at the end, they were evaluated again. RESULTS: A total of 29 patients completed the program (12.7 ± 2.7 sessions). The functional capacity increased in meters walked from 326.3 ± 140.6 to 445.4 ± 151.1 (p < 0.001), with an increase in the predicted value from 59.7% to 82.6% (p < 0.001). The lung function increased in liters from 2.9 ± 0.8 to 3.2 ± 0.8 (p = 0.004) for forced vital capacity and from 2.5 ± 0.7 to 2.7 ± 0.7 (p = 0.001) for forced expiratory volume in the first second. The respiratory muscle strength increased in cmH2O from 101.4 ± 46.3 to 115.8 ± 38.3 (p = 0.117) for inspiratory pressure and from 85.8 ± 32.8 to 106.7 ± 36.8 (p < 0.001) for expiratory pressure. CONCLUSIONS: The pulmonary and functional rehabilitation program provided an improvement in the functional capacity, pulmonary function and respiratory muscle strength in post-COVID-19 patients, restoring their quality of life.